PAN-PROMISE to Detect Post-ERCP Pancreatitis Symptoms
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Michael L Kochman, MD
University of Pennsylvania
Principal Investigator - Mustafa Arain, MD
University of California, San Francisco
Principal Investigator - Nikhil R Thiruvengadam, MD
Loma Linda University School of Medicine.
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
2 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of California, San Francisco
San Francisco, California, United States
- University of Pennsylvania Health System
Philadelphia, Pennsylvania, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 15 Sept 2020
- Primary completion
- 1 Aug 2021
- Completion
- 1 Jan 2023
- Last update posted
- 5 Jul 2023
- Registered enrollment
- 700
- Registry id
- NCT05310409
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 30 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.